JAMES M. DALY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

CHIMERIX INC

Filing Date Source Excerpt
2015-04-29 Mr. Daly is a pharmacist and received his B.S. and M.B.A. degrees from the University of Buffalo, The State University of New York. Our Board of Directors believes that Mr. Daly’s expertise and experience in the biopharmaceutical industry qualifies him to serve on our Board of Directors.
2016-04-28 Mr. Daly is a pharmacist and received his B.S. and M.B.A. degrees from the University of Buffalo, The State University of New York. Our Board of Directors believes that Mr. Daly’s expertise and experience in the biopharmaceutical industry qualifies him to serve on our Board of Directors.
2017-05-01 Mr. Daly is a pharmacist and received his B.S. and M.B.A. degrees from the University of Buffalo, The State University of New York.
2018-04-26 Mr. Daly is a pharmacist and received his B.S. and M.B.A. degrees from the University of Buffalo, The State University of New York.
2019-04-29 Mr. Daly is a pharmacist and received his B.S. and M.B.A. degrees from the University of Buffalo, The State University of New York.
2020-04-28 Listed as a member of the Board Committees but no biography or technical background provided.

HALOZYME THERAPEUTICS, INC.

Filing Date Source Excerpt
2016-03-23 Mr. Daly served as Executive Vice President and Chief Commercial Officer at Incyte Corporation, a biopharmaceutical company.
2017-03-24 Mr. Daly earned his B.S. in Pharmacy and M.B.A. from the University at Buffalo, The State University of New York.
2018-03-22 Mr. Daly earned his B.S. in Pharmacy and M.B.A. from the University at Buffalo, The State University of New York.
2019-03-22 Mr. Daly is an advisor to a number of biotech companies... Mr. Daly earned his B.S. in Pharmacy and M.B.A. from the University at Buffalo.
2020-03-20 Mr. Daly is an advisor to a number of biotechnology companies. Previously, he served as Executive Vice President and Chief Commercial Officer at Incyte Corporation.
2021-03-26 Mr. Daly earned his B.S. in Pharmacy and M.B.A. from The State University of New York at Buffalo.
2022-03-25 Mr. Daly brings more than 30 years of experience leading U.S. and global pharmaceutical businesses to the Board of Directors.
2023-03-24 Mr. Daly earned a BS degree in Pharmacy and his MBA from the University at Buffalo. He has more than 30 years of experience leading pharmaceutical businesses.
2024-03-15 James M. Daly is listed as a director with no detailed biography or technical skills mentioned.

MADRIGAL PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2020-04-29 He earned a B.S. in Pharmacy and an M.B.A. from the University at Buffalo, The State University of New York.
2021-04-30 He earned a B.S. in Pharmacy and an M.B.A. from the University at Buffalo, The State University of New York.
2022-05-02 Mr. Daly has over 30 years of experience leading U.S. and global businesses in the biopharmaceutical industry and also currently serves as a Director of Acadia Pharmaceuticals, argenx SE, Bellicum Pharmaceuticals, and Halozyme Therapeutics.
2023-05-01 Mr. Daly has over 30 years of experience leading U.S. and global businesses in the biopharmaceutical industry and also currently serves as a Director of Acadia Pharmaceuticals, argenx SE, Bellicum Pharmaceuticals, and Halozyme Therapeutics. He previously served on the board of directors of Chimerix, Inc. Most recently, Mr. Daly served as Executive Vice President and Chief Commercial Officer at Incyte Corporation, a publicly-held biopharmaceutical company, from 2012 to 2015. Previously, Mr. Daly worked for Amgen, Inc. and held various leadership positions over a 10-year period, including his last role as Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development. Earlier in his career, he spent over 16 years with Glaxo Wellcome/GlaxoSmithKline (GSK), where he held roles of increasing responsibility, including his last role as Senior Vice President, General Manager of the Respiratory and Anti-Infective Business Unit. He earned a B.S. in Pharmacy and an M.B.A. from the University at Buffalo, The State University of New York.
2024-04-29 Mr. Daly has over 30 years of experience leading U.S. and global businesses in the biopharmaceutical industry.

Data sourced from SEC filings. Last updated: 2026-02-03